Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

A naturally occurring molecule that works as effectively as other semaglutide-based drugs — without the common side effects — ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

If you’ve been paying attention to the weight loss world, you’ve probably heard about GLP-1 receptor agonists like Ozempic, ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as ...

GLP-1 medications, such as Ozempic, reduce cravings. Andy Wardlaw of MMR Research says marketers must now work harder to ...

Metabolic-dysfunction-associated steatotic liver disease (MASLD) arises from excessive intrahepatic triglyceride accumulation ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced presentation of preclinical data supporting the advancement of ...

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...

The news has been littered with stories these days about people losing weight using GLP-1 weight loss drugs like Ozempic. Now ...

Houlihan Lokey's Rainer Hepberger sees a busy deal pipeline, with numerous live transactions and pitch activities.